1180 related articles for article (PubMed ID: 25404125)
1. HDL cholesterol efflux capacity and incident cardiovascular events.
Rohatgi A; Khera A; Berry JD; Givens EG; Ayers CR; Wedin KE; Neeland IJ; Yuhanna IS; Rader DR; de Lemos JA; Shaul PW
N Engl J Med; 2014 Dec; 371(25):2383-93. PubMed ID: 25404125
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
[TBL] [Abstract][Full Text] [Related]
3. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis.
Qiu C; Zhao X; Zhou Q; Zhang Z
Lipids Health Dis; 2017 Nov; 16(1):212. PubMed ID: 29126414
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study.
Liu C; Zhang Y; Ding D; Li X; Yang Y; Li Q; Zheng Y; Wang D; Ling W
Atherosclerosis; 2016 Jun; 249():116-24. PubMed ID: 27088866
[TBL] [Abstract][Full Text] [Related]
6. Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction.
Guerin M; Silvain J; Gall J; Darabi M; Berthet M; Frisdal E; Hauguel-Moreau M; Zeitouni M; Kerneis M; Lattuca B; Brugier D; Collet JP; Lesnik P; Montalescot G
J Am Coll Cardiol; 2018 Dec; 72(25):3259-3269. PubMed ID: 30573028
[TBL] [Abstract][Full Text] [Related]
7. High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events.
Jia C; Anderson JLC; Gruppen EG; Lei Y; Bakker SJL; Dullaart RPF; Tietge UJF
Circulation; 2021 May; 143(20):1935-1945. PubMed ID: 33840204
[TBL] [Abstract][Full Text] [Related]
8. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.
Liao KP; Playford MP; Frits M; Coblyn JS; Iannaccone C; Weinblatt ME; Shadick NS; Mehta NN
J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637346
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
Khera AV; Cuchel M; de la Llera-Moya M; Rodrigues A; Burke MF; Jafri K; French BC; Phillips JA; Mucksavage ML; Wilensky RL; Mohler ER; Rothblat GH; Rader DJ
N Engl J Med; 2011 Jan; 364(2):127-35. PubMed ID: 21226578
[TBL] [Abstract][Full Text] [Related]
10. [HDL and atherosclerotic cardiovascular diseases].
Windler E; Nitschmann S
Internist (Berl); 2015 Apr; 56(4):446-50. PubMed ID: 25700649
[No Abstract] [Full Text] [Related]
11. HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.
Kopecky C; Ebtehaj S; Genser B; Drechsler C; Krane V; Antlanger M; Kovarik JJ; Kaltenecker CC; Parvizi M; Wanner C; Weichhart T; Säemann MD; Tietge UJ
J Am Soc Nephrol; 2017 Mar; 28(3):769-775. PubMed ID: 27612996
[TBL] [Abstract][Full Text] [Related]
12. Relation of black race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study).
Chandra A; Neeland IJ; Das SR; Khera A; Turer AT; Ayers CR; McGuire DK; Rohatgi A
Am J Cardiol; 2015 Apr; 115(7):890-4. PubMed ID: 25661572
[TBL] [Abstract][Full Text] [Related]
13. HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study.
Mutharasan RK; Thaxton CS; Berry J; Daviglus ML; Yuan C; Sun J; Ayers C; Lloyd-Jones DM; Wilkins JT
J Lipid Res; 2017 Mar; 58(3):600-606. PubMed ID: 28049656
[TBL] [Abstract][Full Text] [Related]
14. Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events.
Deets A; Joshi PH; Chandra A; Singh K; Khera A; Virani SS; Ballantyne CM; Otvos JD; Dullaart RPF; Gruppen EG; Connelly MA; Ayers C; Navar AM; Pandey A; Wilkins JT; Rohatgi A
J Am Heart Assoc; 2023 Nov; 12(21):e031160. PubMed ID: 37929707
[TBL] [Abstract][Full Text] [Related]
15. High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: a report from the CREDO-Kyoto registry cohort-2.
Izuhara M; Ono K; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Tada T; Tazaki J; Horie T; Kuwabara Y; Baba O; Nishino T; Kita T; Kimura T;
Atherosclerosis; 2015 Oct; 242(2):632-8. PubMed ID: 26022139
[TBL] [Abstract][Full Text] [Related]
16. HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target.
Bhatt A; Rohatgi A
Curr Atheroscler Rep; 2016 Jan; 18(1):2. PubMed ID: 26710794
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.
Li XM; Tang WH; Mosior MK; Huang Y; Wu Y; Matter W; Gao V; Schmitt D; Didonato JA; Fisher EA; Smith JD; Hazen SL
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1696-705. PubMed ID: 23520163
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese.
Gu X; Yang X; Li Y; Cao J; Li J; Liu X; Chen J; Shen C; Yu L; Huang J; Gu D
Am J Cardiol; 2015 Oct; 116(7):1063-70. PubMed ID: 26250998
[TBL] [Abstract][Full Text] [Related]
19. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
Duprez DA; Otvos J; Tracy RP; Feingold KR; Greenland P; Gross MD; Lima JA; Mackey RH; Neaton JD; Sanchez OA; Jacobs DR
J Am Heart Assoc; 2015 Sep; 4(9):e002295. PubMed ID: 26370448
[TBL] [Abstract][Full Text] [Related]
20. The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study.
Mani P; Ren HY; Neeland IJ; McGuire DK; Ayers CR; Khera A; Rohatgi A
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1(Suppl 1):S175-S179. PubMed ID: 27993539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
